Ladenburg Thalmann Financial Services’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $3.71M | Buy |
66,345
+225
| +0.3% | +$12.6K | 0.02% | 598 |
|
|
2019
Q3 | $3.13M | Buy |
66,120
+153
| +0.2% | +$7.25K | 0.02% | 637 |
|
|
2019
Q2 | $3.53M | Sell |
65,967
-1,018
| -2% | -$54.5K | 0.03% | 581 |
|
|
2019
Q1 | $3.7M | Buy |
66,985
+907
| +1% | +$50.1K | 0.03% | 533 |
|
|
2018
Q4 | $3.11M | Buy |
66,078
+529
| +0.8% | +$24.9K | 0.03% | 518 |
|
|
2018
Q3 | $3.9M | Sell |
65,549
-197
| -0.3% | -$11.7K | 0.03% | 468 |
|
|
2018
Q2 | $3.23M | Hold |
65,746
| – | – | 0.03% | 503 |
|
|
2018
Q1 | $3.23M | Buy |
65,746
+186
| +0.3% | +$9.14K | 0.03% | 503 |
|
|
2017
Q4 | $3.09M | Buy |
65,560
+6,736
| +11% | +$318K | 0.03% | 520 |
|
|
2017
Q3 | $2.94M | Buy |
58,824
+1,486
| +3% | +$74.2K | 0.03% | 478 |
|
|
2017
Q2 | $2.62M | Buy |
57,338
+14,811
| +35% | +$676K | 0.03% | 486 |
|
|
2017
Q1 | $1.8M | Buy |
42,527
+6,224
| +17% | +$263K | 0.02% | 611 |
|
|
2016
Q4 | $1.41M | Buy |
36,303
+27,750
| +324% | +$1.08M | 0.02% | 673 |
|
|
2016
Q3 | $359K | Buy |
8,553
+381
| +5% | +$16K | 0.01% | 1372 |
|
|
2016
Q2 | $302K | Buy |
8,172
+50
| +0.6% | +$1.85K | ﹤0.01% | 1406 |
|
|
2016
Q1 | $310K | Sell |
8,122
-481
| -6% | -$18.4K | 0.01% | 1317 |
|
|
2015
Q4 | $435K | Buy |
8,603
+1,011
| +13% | +$51.1K | 0.01% | 1101 |
|
|
2015
Q3 | $346K | Buy |
7,592
+1,238
| +19% | +$56.4K | 0.01% | 1162 |
|
|
2015
Q2 | $370K | Sell |
6,354
-653
| -9% | -$38K | 0.01% | 1213 |
|
|
2015
Q1 | $386K | Sell |
7,007
-348
| -5% | -$19.2K | 0.01% | 1177 |
|
|
2014
Q4 | $370K | Buy |
7,355
+1,457
| +25% | +$73.3K | 0.01% | 1076 |
|
|
2014
Q3 | $273K | Buy |
5,898
+58
| +1% | +$2.69K | 0.01% | 1063 |
|
|
2014
Q2 | $255K | Sell |
5,840
-7,647
| -57% | -$334K | 0.01% | 1068 |
|
|
2014
Q1 | $561K | Sell |
13,487
-68
| -0.5% | -$2.83K | 0.02% | 682 |
|
|
2013
Q4 | $502K | Buy |
13,555
+9,399
| +226% | +$348K | 0.02% | 686 |
|
|
2013
Q3 | $146K | Buy |
4,156
+1,259
| +43% | +$44.2K | ﹤0.01% | 1173 |
|
|
2013
Q2 | $84K | Buy |
+2,897
| New | +$84K | ﹤0.01% | 1406 |
|